Market Place
Sourcing Support
UK`s Recommends Use of GSK Unit`s HIV Prevention Drug
16 Oct 2025 //
REUTERS
Scynexis Secures $22M Payout From GSK After Trial Dispute
15 Oct 2025 //
FIERCE PHARMA
GSK Tout Study Showing Tolerability Edge for Its Long-Acting PrEP
15 Oct 2025 //
FIERCE PHARMA
GSK`s Shingrix Approved In China For Shingles Prevention
14 Oct 2025 //
PHARMIWEB
Clover Reveals Encouraging Phase I Results For RSV Vaccines
14 Oct 2025 //
PR NEWSWIRE
Spero Pharma Presents Tebipenem Hbr Data At IDweek
14 Oct 2025 //
GLOBENEWSWIRE
GSK`s Nashik Plant Receives Global BSI AMR Kitemark Certification
13 Oct 2025 //
EXPRESSPHARMA
Kennedy Push For Autism Drug Gets A Boost From Pharma
06 Oct 2025 //
REUTERS
As 2 Ceos Depart, Life Sciences Face Leadership Void For Women
03 Oct 2025 //
FIERCE BIOTECH
GSK Overturns Pmcpa`s Most Serious Sanction In COVID Release Row
03 Oct 2025 //
FIERCE PHARMA
GSK Pharma Boosted By New Launches And Base Business Traction
02 Oct 2025 //
BUSINESS STD
Who is GSK`s next CEO Luke Miels
30 Sep 2025 //
REUTERS
Pi Health Partners GSK To Boost Clinical Research Services
24 Sep 2025 //
BUSINESSWIRE
FDA Approves Drug that Trump Due to Suggest as Autism Treatment
24 Sep 2025 //
REUTERS
GSK Plots $30 B Investment in US Manufacturing, R&D
17 Sep 2025 //
PRESS RELEASE
GSK Adds Moderna`s Next-Gen Covid Shot to MRNA Patent Lawsuit
05 Sep 2025 //
FIERCE PHARMA
GSK forays into oncology in India with Jemperli and Zejula
25 Aug 2025 //
INDPHARMAPOST
Iterum Pursues Dual-Track Strategy for First UTI Drug in 25 Years
20 Aug 2025 //
FIERCE PHARMA
GSK`s Gepotidacin Gets Priority Review from U.S. FDA
11 Aug 2025 //
CONTRACTPHARMA
GSK Pharma Q1 PAT rises 12% to 279 cr, income marginally down
01 Aug 2025 //
BUSINESS STD
GSK anti-TIM-3 antibody flunks ph. 3, as TIGIT fail costs $629M
31 Jul 2025 //
FIERCE BIOTECH
GSK Holds to Its £40B Projection for 2031, Despite Blenrep Woes
31 Jul 2025 //
FIERCE PHARMA
GSK to Invest Billions in US Amid Tariff, Pipeline Changes
30 Jul 2025 //
BIOSPACE
AbbVie, Gilead, GSK Support Annual Hepatitis Elimination Drive
29 Jul 2025 //
FIERCE PHARMA
Jiangsu Hengrui Grants GSK global rights to Drug portfolio
29 Jul 2025 //
REUTERS
GSK`s Blood Cancer Drug gets EU Approval
26 Jul 2025 //
REUTERS
GSK Presents Tv Special on Senior Athletes for Rsv Awareness
25 Jul 2025 //
FIERCE PHARMA
FDA Delays Decision on GSK`s Blenrep Comeback by 3 Months
24 Jul 2025 //
FIERCE PHARMA
GSK`s Blenrep Receives Approval in Europe
23 Jul 2025 //
EMA
GSK`s Production Shift in Massachusetts Causes 150 Layoffs
22 Jul 2025 //
FIERCE PHARMA
GSK`s Blood Cancer Drug Fails to Secure FDA Advisers` Support
18 Jul 2025 //
REUTERS
FDA Approves Pre-filled Version of GSK`s Shingles Vaccine
18 Jul 2025 //
PRESS RELEASE
GlaxoSmithKline`s Blenrep Receives Approval in Canada
17 Jul 2025 //
HEALTH CANADA
FDA Staff Flags Eye Safety Risks for GSk`s Blood Cancer Drug
16 Jul 2025 //
REUTERS
GSK Plans `very Limited` Job Cuts for Global R&D Team
15 Jul 2025 //
FIERCE BIOTECH
89% of HIV Patients Choose ViiV’s Long-Acting Injection
14 Jul 2025 //
BUSINESSWIRE
Delaware Court Backs Zantac Drugmakers in Cancer Lawsuits
12 Jul 2025 //
REUTERS
GSK Appoints Vishwanath Swarup as Gen Meds Commercial Head
11 Jul 2025 //
INDPHARMAPOST
GSK Ships Influenza Vaccine Doses for 2025-26 Flu Season
10 Jul 2025 //
BUSINESSWIRE
NPPA Notifies Separate Retail Price of GSK`s Cold Medicine
08 Jul 2025 //
PHARMABIZ
US Senator Probes GSK`s Halt of Children`s Asthma Inhaler
28 Jun 2025 //
REUTERS
Bharat, GSK to halve price of malaria vaccine by 2028
26 Jun 2025 //
FIERCE PHARMA
FDA Approved Benlysta Autoinjector for Kids with Lupus Nephritis
24 Jun 2025 //
BUSINESSWIRE
GSK`s Biologics Benlysta Receives Suppl Approval in US
20 Jun 2025 //
FDA
GSK Offloads Shigella Vaccine to Bharat Biotech Ahead of Phase 3
14 Jun 2025 //
PRESS RELEASE
Committee Sets Retail Price for Gsk Cold Medicine
13 Jun 2025 //
PHARMABIZ
GSK Applies to EU regulator for Expanded Use of RSV Vaccine
12 Jun 2025 //
REUTERS
EHA: Gearing up for US comeback, GSK details Blenrep`s PFS win
12 Jun 2025 //
FIERCE PHARMA
FDA Accepts NDA for Linerixibat in PBC-Related Itch
07 Jun 2025 //
PRESS RELEASE
Theravance Sells Remaining Trelegy Royalties To GSK For $225M
02 Jun 2025 //
PR NEWSWIRE
GSK, Spero stop UTI drug trial after early success
29 May 2025 //
REUTERS
Scynexis Resumes Patient Dosing in Phase 3 Mario Study
28 May 2025 //
GLOBENEWSWIRE
CHMP signs off on GSK`s comeback ADC cancer drug Blenrep
23 May 2025 //
FIERCE PHARMA
GSK`s asthma drug wins FDA approval to treat `smoker`s lung
23 May 2025 //
REUTERS
GSK Revs up Launch Plans After Nucala`s FDA Approval in COPD
22 May 2025 //
FIERCE PHARMA
GSK`s Biologics Nucala Receives Suppl Approval in US
22 May 2025 //
FDA
GSK to buy liver disease drug for up to $2 billion
15 May 2025 //
PRESS RELEASE
GlaxoSmithKline Pharmaceuticals posts FY25 PAT at Rs. 915 Cr
14 May 2025 //
INDPHARMAPOST
GSK, partner iTeos scrap development of lung cancer therapy
14 May 2025 //
REUTERS
Gsk and Lifetime Launch Movie on Meningitis Impact
09 May 2025 //
BUSINESSWIRE
